Coverage
-
July 06, 2020
A Delaware federal judge on Monday extended his finding that generic-drug makers infringed valid claims for patents covering Teva's cancer drug Bendeka to dozens of untried patent claims, saying pretrial agreements to do so applied no matter which side won.
1 other articles on this case.
View all »